Skip to main content
HYUNDAI FEED Inc. logo

HYUNDAI FEED Inc. — Investor Relations & Filings

Ticker · 016790 ISIN · KR7016790008 KO Manufacturing
Filings indexed 653 across all filing types
Latest filing 2024-02-27 Director's Dealing
Country KR South Korea
Listing KO 016790

About HYUNDAI FEED Inc.

http://www.hdfd.co.kr/

HYUNDAI FEED Inc. is a company engaged in the manufacturing and sale of animal feed and nutrition products. Its core business involves the production of formulated feeds for the livestock industry. The company's main products consist of feed for poultry and pigs.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in Korea. This type of filing is used to disclose changes in share ownership by major shareholders or insiders. According to the provided definitions, this falls under 'Director's Dealing' (DIRS) as it reports share transactions by a major shareholder (Sejong Medical) in the issuing company (Canaria Bio).
2024-02-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when a shareholder's stake in a company changes significantly (crossing thresholds). This document details the change in shareholding percentage by Sejong Medical in Canaria Bio. Since it is a specific regulatory notification regarding major shareholding changes, it falls under the 'Major Shareholding Notification' category.
2024-02-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when a major shareholder or executive changes their stake in a company. Since the document details the sale of shares by a major shareholder (Sejong Medical) in the issuing company (Canaria Bio), it falls under the category of 'Director's Dealing' (DIRS), which covers insider and major shareholder transactions.
2024-02-19 Korean
전환가액의조정 (제5회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of the conversion price for convertible bonds (5th series) issued by CanariaBio. This type of filing, which details changes to capital structure instruments like convertible bonds due to market price fluctuations, falls under the category of capital and financing updates.
2024-02-19 Korean
전환가액의조정 (제4회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the 'Adjustment of Conversion Price' (전환가액의 조정) for convertible bonds. This type of filing details changes to the capital structure, specifically the conversion price of debt into equity due to market price fluctuations. This falls under the category of capital and financing updates, as it directly impacts the company's capital structure and potential share dilution.
2024-02-19 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of the conversion price for convertible bonds (CB) due to a decline in market price. This type of disclosure, which details changes to capital structure instruments like convertible bonds, falls under 'Capital/Financing Update' (CAP) as it directly relates to the company's financing activities and debt-to-equity conversion terms.
2024-02-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.